about
The germinal center antibody response in health and diseaseContribution of Toll-like receptor signaling to germinal center antibody responsesCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Vaccines: the Fourth CenturyChimeric infectious bursal disease virus-like particles as potent vaccines for eradication of established HPV-16 E7-dependent tumorsVersatile virus-like particle carrier for epitope based vaccinesExploiting virus-like particles as innovative vaccines against emerging viral infectionsMax Bergmann lecture protein epitope mimetics in the age of structural vaccinologyComputational tools for epitope vaccine design and evaluationFormulation of microneedles coated with influenza virus-like particle vaccine.Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.A vaccine of L2 epitope repeats fused with a modified IgG1 Fc induced cross-neutralizing antibodies and protective immunity against divergent human papillomavirus types.Mining human antibody repertoires.Newcastle disease virus-like particles: preparation, purification, quantification, and incorporation of foreign glycoproteinsCell-free protein synthesis: applications come of age.Surface functionalization of virus-like particles by direct conjugation using azide-alkyne click chemistryNanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines.Assembly and biological and immunological properties of Newcastle disease virus-like particles.Vaccine potential of Nipah virus-like particlesA VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.Colorful virus-like particles: fluorescent protein packaging by the Qβ capsid.Rationalizing the development of live attenuated virus vaccinesConstruction and characterization of insect cell-derived influenza VLP: cell binding, fusion, and EGFP incorporation.Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins.Development of a mimotope vaccine targeting the Staphylococcus aureus quorum sensing pathway.Titrating T-cell epitopes within self-assembled vaccines optimizes CD4+ helper T cell and antibody outputsA retrospective analysis of the Alzheimer's disease vaccine progress - The critical need for new development strategies.Bacterially produced recombinant influenza vaccines based on virus-like particles.Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.Non-carrier nanoparticles adjuvant modular protein vaccine in a particle-dependent manner.The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease.Protein delivery using engineered virus-like particles.Progress in understanding and controlling respiratory syncytial virus: still crazy after all these yearsAffinity selection of epitope-based vaccines using a bacteriophage virus-like particle platformIdentification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide DisplayMurine immune responses to virus-like particle-associated pre- and postfusion forms of the respiratory syncytial virus F proteinInduction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain.Epitope-Specific Anti-hCG Vaccines on a Virus Like Particle Platform.A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA.A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria.
P2860
Q26745929-8C0F83C4-02C8-4880-BBAE-D1E96B89926CQ26829061-A9912907-761F-4DC2-AAD8-EB80168ECA46Q26830028-DB8D8943-9DDE-4E18-AABC-AF755E2EE082Q27490454-5F43D2DC-E65C-4825-B9BB-9C5DA84F2E72Q28484683-7B76AF52-96EF-4358-BE6E-DB3F270A9E98Q28748358-5F6BB6D5-68D5-4BB6-B042-18F2395B3CB0Q29365799-B3D41F6A-B6DA-4D19-9C15-BD85D8DD6F98Q30155145-074D194A-0B54-4CDB-9D95-2BBE23EDC3E2Q30373339-CFFE0FB8-C0FC-4CBB-A603-29A065A5DF08Q30392132-1620370A-6308-4977-8ABE-FF8C6C476276Q33558475-9DA3276E-B0B6-4C07-A64B-7679B076942DQ33572691-3AFB0716-B96E-43CC-B609-A8184E98B0E1Q33588489-8A69D0DB-0750-4207-BE2E-CEC181CAC680Q33677863-BA82662C-2C47-4304-8AC0-CB6114C770FEQ33684275-185F116F-6B64-4C3E-A156-427482A3DDB1Q33707408-6207D5E5-E880-4019-B06B-3736FABFC058Q33812439-8B7030B5-6B34-4BE4-93AE-1BA8A5B4FCE4Q33826688-25F222C1-63D9-487B-BDC3-E274DB0127B1Q33873756-52226828-3D1D-47DD-AE0E-ECDE10B6EDF3Q34039347-24DC3C5A-EE66-4C4E-B7DC-66FBDC872068Q34047594-EE1EC21B-7660-4704-A876-6416B2713DE3Q34119676-A2E4E4D0-09E3-44F0-93CE-38C4636E4525Q34416974-9169BEB2-F067-48D3-8C79-22EC3EC9ED9BQ34457791-178C6620-0392-4033-B1EC-623E0FCAB49DQ34472793-8F785287-8950-4413-87F6-446984DDBBB9Q34490296-3E156B0F-463F-40F9-BE29-04CF08D95E06Q34518856-0C2B1660-2B0D-44E6-858C-C592377ED2CEQ35048127-F427B4C2-FCE1-44E7-A2DF-6E33ADECBDFCQ35076683-7D94C215-F413-475D-9CBF-0C2F421B4939Q35165017-127EAACF-9552-4903-BF6F-3CF3FDC7A7BCQ35183183-3B272368-3E73-4F16-B262-82D7C72E34BBQ35345000-C7A0F846-3FBC-49DF-83C2-83FDB0E76BE4Q35566601-D88A33E0-082B-44B3-946B-8CD72EBB14DAQ35591551-285B67E3-EA42-4BEE-9454-D7C557B398EBQ35683634-B5CC537D-8C0C-49F4-B403-370F261367CDQ35745343-E8481894-0F48-4D15-81BE-867DAC21FB47Q35772032-37B34838-3146-47F4-8356-D87EA28D6840Q35827034-FEC5E824-D8F2-4E63-9951-B5C5C5A646B9Q35850159-CE3D0BB0-34E1-4FEC-B247-4F8D93677FA0Q35927866-62E32F1E-AD0A-4BC7-BF02-921223B089C0
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The coming of age of virus-like particle vaccines.
@en
The coming of age of virus-like particle vaccines.
@nl
type
label
The coming of age of virus-like particle vaccines.
@en
The coming of age of virus-like particle vaccines.
@nl
prefLabel
The coming of age of virus-like particle vaccines.
@en
The coming of age of virus-like particle vaccines.
@nl
P2860
P356
P1433
P1476
The coming of age of virus-like particle vaccines.
@en
P2093
Gary T Jennings
Martin F Bachmann
P2860
P304
P356
10.1515/BC.2008.064
P577
2008-05-01T00:00:00Z